Scarica l'app Stockscreener
31.52
1.19%
-0.38
Dopo l'orario di chiusura:
30.00
-1.52
-4.82%
Precedente Chiudi:
$31.90
Aprire:
$32.05
Volume 24 ore:
635.06K
Relative Volume:
0.70
Capitalizzazione di mercato:
$2.76B
Reddito:
$214.83M
Utile/perdita netta:
$-160.74M
Rapporto P/E:
-16.99
EPS:
-1.8553
Flusso di cassa netto:
$-105.39M
1 W Prestazione:
-0.79%
1M Prestazione:
-14.44%
6M Prestazione:
+33.62%
1 anno Prestazione:
+43.60%
Intervallo 1D:
$30.74
$32.17
Intervallo di 1 settimana:
$30.74
$33.62
Portata 52W:
$13.45
$39.28
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Nome
Ideaya Biosciences Inc
Settore
Industria
Telefono
650-443-6209
Indirizzo
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare IDYA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
31.52 | 2.80B | 214.83M | -160.74M | -105.39M | -1.8553 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-09-04 | Iniziato | Barclays | Overweight |
| 2025-09-04 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Iniziato | TD Cowen | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-06-26 | Iniziato | Wells Fargo | Overweight |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-11-05 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Iniziato | Mizuho | Outperform |
| 2024-03-08 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | SVB Securities | Outperform |
| 2023-05-24 | Iniziato | Goldman | Buy |
| 2023-04-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-23 | Iniziato | Berenberg | Buy |
| 2023-02-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-28 | Iniziato | CapitalOne | Overweight |
| 2022-10-27 | Iniziato | Citigroup | Buy |
| 2022-08-15 | Downgrade | Stifel | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2022-03-10 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-11 | Iniziato | Guggenheim | Buy |
| 2020-10-07 | Iniziato | Wedbush | Outperform |
| 2020-09-01 | Iniziato | Northland Capital | Outperform |
| 2020-07-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-06 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-13 | Iniziato | ROTH Capital | Buy |
| 2019-10-17 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-17 | Iniziato | Citigroup | Buy |
| 2019-06-17 | Iniziato | JP Morgan | Neutral |
| 2019-06-17 | Iniziato | Jefferies | Buy |
Mostra tutto
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
IDEAYA Biosciences, Inc. $IDYA Shares Acquired by Candriam S.C.A. - MarketBeat
Citizens reiterates Market Outperform rating on Ideaya Biosciences stock By Investing.com - Investing.com Canada
IDEAYA Biosciences (IDYA): Unpacking The 46.63% Potential Upside In Precision Oncology - DirectorsTalk Interviews
IDEAYA Biosciences, Inc. $IDYA Shares Acquired by New York State Common Retirement Fund - MarketBeat
Liquidity Mapping Around (IDYA) Price Events - Stock Traders Daily
IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events - MEXC
Has The Market Overreacted To Recent Weakness In IDEAYA Biosciences (IDYA) Shares? - Yahoo Finance
AlphaQuest LLC Has $1.12 Million Stock Position in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Institution Moves: Is IDEAYA Biosciences Inc benefiting from innovation trends2025 Support & Resistance & Safe Capital Investment Plans - baoquankhu1.vn
A Look At IDEAYA Biosciences (IDYA) Valuation After Recent Share Price Pullback - Yahoo Finance
Knights of Columbus Asset Advisors LLC Invests $934,000 in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
IDEAYA Grants 44,200 Stock Options to New Employee - intellectia.ai
Ideaya Biosciences announces inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com
New IDEAYA hire receives 44,200 stock options in Nasdaq inducement grant - stocktitan.net
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - TradingView
Forecast Cut: Will IDEAYA Biosciences Inc benefit from geopolitical trendsWatch List & Consistent Income Trade Recommendations - baoquankhu1.vn
What are IDEAYA Biosciences Inc.’s recent SEC filings showingIPO Watch & Daily Profit Maximizing Trade Tips - mfd.ru
IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Potential 44.88% Upside Fuels Investor Interest - DirectorsTalk Interviews
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Weekly Trades: What chart patterns are forming on IDEAYA Biosciences IncMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Why (IDYA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Street Watch: What is IDEAYA Biosciences Inc. s P E ratio telling usQuarterly Risk Review & Short-Term Swing Trade Alerts - baoquankhu1.vn
Sectors Review: Whats the beta of IDEAYA Biosciences Inc stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - baoquankhu1.vn
RBC Raises Price Target on IDEAYA Biosciences to $45 From $41, Keeps Outperform, Speculative Risk - marketscreener.com
IDEAYA Biosciences (IDYA) Stock Analysis: A Promising Upside of 38.69% in Precision Medicine - DirectorsTalk Interviews
Winners Losers: Is IDEAYA Biosciences Inc subject to activist investor interestQuarterly Market Summary & AI Driven Stock Reports - baoquankhu1.vn
Ideaya Biosciences advances with IDE892 study targeting MTAP-deleted tumors - MSN
IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC - MarketBeat
FEDERATED HERMES, INC. Reduces Stake in IDEAYA Biosciences Inc - GuruFocus
IDEAYA Biosciences (IDYA) Stock Analysis: A Biotech Gem With A Potential 34.92% Upside - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Understanding Momentum Shifts in (IDYA) - Stock Traders Daily
IDEAYA Biosciences Outlines 2026 Corporate Objectives and Clinical Progress - Intellectia AI
IDEAYA Biosciences Updates 2026 Corporate Objectives at J.P. Morgan Conference - Intellectia AI
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference – Company AnnouncementFT.com - Financial Times
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
IDEAYA Biosciences Updates 2026 Strategic Objectives, Plans to Advance Four Registrational Trials - Intellectia AI
Why IDEAYA Biosciences Inc. stock attracts global investors2025 Market Overview & Safe Capital Growth Stock Tips - ulpravda.ru
How buybacks impact IDEAYA Biosciences Inc. stock valueWeekly Risk Summary & Fast Gain Stock Trading Tips - Улправда
Why IDEAYA Biosciences Inc. stock is considered a top pickFit and Size Notes & walk-ready comfort choices - Улправда
GSK ends collaboration with IDEAYA for two candidates - MSN
Earnings Recap: How analysts rate IDEAYA Biosciences Inc. stock todayTake Profit & Safe Capital Growth Tips - Улправда
Why IDEAYA Biosciences Inc. stock remains on buy listsJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
What downside risks could hit IDEAYA Biosciences Inc. (30J) stockQuarterly Portfolio Review & Verified Entry Point Detection - Улправда
Ideaya Biosciences stock hits 52-week high at 37.09 USD By Investing.com - Investing.com Nigeria
IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month HighStill a Buy? - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Coverage Initiated at UBS Group - MarketBeat
Ideaya Biosciences stock hits 52-week high at 37.09 USD - Investing.com
Ideaya Biosciences stock gets Buy rating from UBS with $50 price target - Investing.com Canada
Will IDEAYA Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team group stage star players high defensive line odds analysis guide - Улправда
Will IDEAYA Biosciences Inc. stock outperform growth indexes2026 world cup usa national team third place match goalkeepers possession football group prediction preview - ulpravda.ru
Ideaya Biosciences Inc Azioni (IDYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):